Thursday 23 March 2017
 
»
Tag
 
»
Julphar

Julphar sees market growth this year

The UAE-based Julphar, a leading pharmaceutical company in the region, expects the regional market to improve this year. “Despite the difficult and uncertain times in the regional economic cycle, overall, the company is expe

More…

Julphar sees market growth this year

The UAE-based Julphar, a leading pharmaceutical company in the region, expects the regional market to improve this year. “Despite the difficult and uncertain times in the regional economic cycle, overall, the company is expe

More…

Julphar CEO to leave in Q2

Julphar chief executive officer Dr Ayman Sahli has decided to leave the company in the second quarter of this year, when his contract expires. The Julphar board said it respects his wishes and has accepted his decision. The process to s

More…

Julphar appoints new chief financial officer

UAE-based Julphar, a leading generic pharmaceutical manufacturer in Middle East and North Africa (Mena) region, has appointed Jerome Carle as its new chief financial officer. In his new role, Carle will be responsible for leading

More…

Julphar launches new antibiotic in UAE

Julphar Gulf Pharmaceutical Industries recently launched the antibiotic Voxin in the UAE during an event held at the Raffles Hotel, Dubai. “Voxin (Levofloxacin) is a fluoroquinolone antibiotic that is indicated for the treat

More…

Julphar reports revenue of $290m

UAE-based Julphar Gulf Pharmaceutical Industries, a leading generic pharmaceutical manufacturer in Middle East and North Africa (Mena) region, has reported sales revenue of Dh1.066 billion ($290.2 million) in the first nine months of this year.

More…

Swiss Ambassador visits Julphar

The UAE-based pharmaceutical manufacturer Julphar Gulf Pharmaceutical Industries recently invited Maya Tissafi, Ambassador of Switzerland to the UAE, to visit its head office in Ras Al Khaimah. Tissafi was welcomed by Sheikh Faisa

More…

Julphar launches two medicines for Type 2 diabetes

The UAE-based pharmaceutical manufacturer Julphar Gulf Pharmaceutical Industries has launched two new medications for the management of Type 2 diabetes -- Xelevia and Velmetia. The launch is part of Julphar’s licence, supply

More…

Julphar to manufacture pharmaceuticals in Bangladesh

Julphar Bangladesh, a subsidiary of the Ras Al Khaimah-based Julphar Gulf Pharmaceutical Industries, has signed a strategic toll agreement with the Bangladeshi non-profit company SMC Enterprise Limited (SMC) to manufacture pharmaceutical product

More…

Julphar sales total $400m in 2015

Ras Al Khaimah-based Julphar (Gulf Pharmaceutical Industries) recorded sales totalling Dh1.47 billion ($400.11 million) in 2015, an increase of 6 per cent compared to the previous year, it was revealed at the company’s general assembly rec

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads